Shareholder Activism
Helping public companies assess risk and navigate the challenges that management and boards face in activist campaigns
Why Cooley
-
Multidisciplinary, customized approach helps public companies assess conditions, formulate action plans and execute when faced with activists
-
Team includes former SEC employees and industry-recognized lawyers in corporate governance and securities, capital markets and class action litigation
-
Broad experience with all areas relevant to activist campaigns, including proxy contests, shareholder communications, advance notice bylaw provisions and internal investigations
-
Experienced in advising clients in takeover and defense engagements, including poison pills
Pubco @ Cooley Blog
Focus on providing dynamic thought leadership and curated content for the public securities arena.
M&A Blog
Dynamic thought leadership and newsworthy developments in the global mergers and acquisitions space
Triggering Events for Form 8-K
Quick Reference Guide
Cooley’s shareholder activism practice is an established presence for clients in the life sciences and pharmaceutical industries, advising established and next-generation public companies on challenges faced by activist investors, including poison pills, proxy contests, board nominations and unsolicited takeover offers.
The Legal 500 US (2025)
Group contacts
